Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer-a commentary from the Young International Society of Geriatric Oncology

doi:10.1016/j.annonc.2023.02.007

Comment

. 2023 Jun;34(6):555-556.

doi: 10.1016/j.annonc.2023.02.007. Epub 2023 Feb 21.

Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer-a commentary from the Young International Society of Geriatric Oncology

G Liposits¹, S P Arora², N M L Battisti³, E Soto-Perez-de-Celis⁴, K P Loh⁵, G R Williams⁶

Affiliations

¹ Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense, Denmark. Electronic address: gabor.istvan.liposits@rsyd.dk.
² Division of Hematology/Oncology, Mays Cancer Center, University of Texas Health San Antonio, San Antonio, USA. Electronic address: https://twitter.com/DrSukeshiArora.
³ Department of Medicine, The Royal Marsden NHS Foundation Trust, Sutton, UK; Breast Cancer Research Division, The Institute of Cancer Research, Sutton, London, UK. Electronic address: https://twitter.com/nicolobattisti.
⁴ Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: https://twitter.com/EnriqueSoto8.
⁵ Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA. Electronic address: https://twitter.com/MelissaLoh21.
⁶ Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, USA. Electronic address: https://twitter.com/GrantWilliamsMD.

PMID: 36813114
DOI: 10.1016/j.annonc.2023.02.007

Free article

Comment

Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer-a commentary from the Young International Society of Geriatric Oncology

G Liposits et al. Ann Oncol. 2023 Jun.

Free article

. 2023 Jun;34(6):555-556.

doi: 10.1016/j.annonc.2023.02.007. Epub 2023 Feb 21.

Authors

G Liposits¹, S P Arora², N M L Battisti³, E Soto-Perez-de-Celis⁴, K P Loh⁵, G R Williams⁶

Affiliations

¹ Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense, Denmark. Electronic address: gabor.istvan.liposits@rsyd.dk.
² Division of Hematology/Oncology, Mays Cancer Center, University of Texas Health San Antonio, San Antonio, USA. Electronic address: https://twitter.com/DrSukeshiArora.
³ Department of Medicine, The Royal Marsden NHS Foundation Trust, Sutton, UK; Breast Cancer Research Division, The Institute of Cancer Research, Sutton, London, UK. Electronic address: https://twitter.com/nicolobattisti.
⁴ Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: https://twitter.com/EnriqueSoto8.
⁵ Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA. Electronic address: https://twitter.com/MelissaLoh21.
⁶ Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, USA. Electronic address: https://twitter.com/GrantWilliamsMD.

PMID: 36813114
DOI: 10.1016/j.annonc.2023.02.007

No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors have declared no conflicts of interest.

Comment on

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Vogel A, Bridgewater J, Edeline J, Kelley RK, Klümpen HJ, Malka D, Primrose JN, Rimassa L, Stenzinger A, Valle JW, Ducreux M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Vogel A, et al. Ann Oncol. 2023 Feb;34(2):127-140. doi: 10.1016/j.annonc.2022.10.506. Epub 2022 Nov 10. Ann Oncol. 2023. PMID: 36372281 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer-a commentary from the Young International Society of Geriatric Oncology

Affiliations

Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer-a commentary from the Young International Society of Geriatric Oncology

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical